408 related articles for article (PubMed ID: 11861969)
1. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
Johnson DR; Habeebu SS; Klaassen CD
Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
[TBL] [Abstract][Full Text] [Related]
2. Role of rat multidrug resistance protein 2 in plasma and biliary disposition of dibromosulfophthalein after microsomal enzyme induction.
Johnson DR; Klaassen CD
Toxicol Appl Pharmacol; 2002 Apr; 180(1):56-63. PubMed ID: 11922777
[TBL] [Abstract][Full Text] [Related]
3. The effects of hepatic microsomal enzyme inducers on the pharmacokinetics of ouabain after portal and systemic administration to rats.
Thompson TN; Klaassen CD
J Pharm Pharmacol; 1995 Dec; 47(12A):1041-7. PubMed ID: 8932692
[TBL] [Abstract][Full Text] [Related]
4. Mrp2 is involved in benzylpenicillin-induced choleresis.
Ito K; Koresawa T; Nakano K; Horie T
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G42-9. PubMed ID: 15194559
[TBL] [Abstract][Full Text] [Related]
5. Effect of microsomal enzyme inducers on the biliary excretion of triiodothyronine (T(3)) and its metabolites.
Vansell NR; Klaassen CD
Toxicol Sci; 2002 Feb; 65(2):184-91. PubMed ID: 11812922
[TBL] [Abstract][Full Text] [Related]
6. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites.
Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H
Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748
[TBL] [Abstract][Full Text] [Related]
7. Role of glutathione and hepatic glutathione S-transferase in the biliary excretion of methyl mercury, cadmium and zinc: a study with enzyme inducers and glutathione depletors.
Gregus Z; Varga F
Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):398-403. PubMed ID: 4036632
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of microsomal enzyme-inducing chemicals on the hepatic expression of rat organic anion transporters, OATP1 and OATP2.
Rausch-Derra LC; Hartley DP; Meier PJ; Klaassen CD
Hepatology; 2001 Jun; 33(6):1469-78. PubMed ID: 11391536
[TBL] [Abstract][Full Text] [Related]
9. Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats.
Chen C; Scott D; Hanson E; Franco J; Berryman E; Volberg M; Liu X
Pharm Res; 2003 Jan; 20(1):31-7. PubMed ID: 12608533
[TBL] [Abstract][Full Text] [Related]
10. Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions.
Patel NJ; Zamek-Gliszczynski MJ; Zhang P; Han YH; Jansen PL; Meier PJ; Stieger B; Brouwer KL
Mol Pharmacol; 2003 Jul; 64(1):154-9. PubMed ID: 12815171
[TBL] [Abstract][Full Text] [Related]
11. Effect of P-450 inducers on biliary excretion of glutathione and its hydrolysis products. Correlation between hepatic gamma-glutamyltranspeptidase activity and the proportion of glutathione hydrolysis products in bile.
Madhu C; Mitchell DY; Klaassen CD
Drug Metab Dispos; 1993; 21(2):342-9. PubMed ID: 8097707
[TBL] [Abstract][Full Text] [Related]
12. Expression of rat Multidrug Resistance Protein 2 (Mrp2) in male and female rats during normal and pregnenolone-16alpha-carbonitrile (PCN)-induced postnatal ontogeny.
Johnson DR; Guo GL; Klaassen CD
Toxicology; 2002 Sep; 178(3):209-19. PubMed ID: 12167307
[TBL] [Abstract][Full Text] [Related]
13. Increased biliary excretion of thyroxine by microsomal enzyme inducers.
Vansell NR; Klaassen CD
Toxicol Appl Pharmacol; 2001 Nov; 176(3):187-94. PubMed ID: 11714251
[TBL] [Abstract][Full Text] [Related]
14. Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats.
Lu SC; Cai J; Kuhlenkamp J; Sun WM; Takikawa H; Takenaka O; Horie T; Yi J; Kaplowitz N
Hepatology; 1996 Jul; 24(1):253-8. PubMed ID: 8707271
[TBL] [Abstract][Full Text] [Related]
15. Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.
Yue W; Lee JK; Abe K; Sugiyama Y; Brouwer KL
Drug Metab Dispos; 2011 Mar; 39(3):441-7. PubMed ID: 21106720
[TBL] [Abstract][Full Text] [Related]
16. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan.
Nishino A; Kato Y; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931
[TBL] [Abstract][Full Text] [Related]
17. Biliary excretion of drugs: role of ligandin in newborn immaturity and in the action of microsomal enzyme inducers.
Klaassen CD
J Pharmacol Exp Ther; 1975 Nov; 195(2):311-9. PubMed ID: 1185600
[TBL] [Abstract][Full Text] [Related]
18. Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2.
Morikawa A; Goto Y; Suzuki H; Hirohashi T; Sugiyama Y
Pharm Res; 2000 May; 17(5):546-52. PubMed ID: 10888306
[TBL] [Abstract][Full Text] [Related]
19. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
[TBL] [Abstract][Full Text] [Related]
20. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats.
Gotoh Y; Suzuki H; Kinoshita S; Hirohashi T; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):433-9. PubMed ID: 10604980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
